Co-Authors
This is a "connection" page, showing publications co-authored by Xia Xiao and Tao Jiao.
Connection Strength
0.348
-
Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2. Front Immunol. 2020; 11:586572.
Score: 0.229
-
Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants. Emerg Microbes Infect. 2021 Dec; 10(1):1227-1240.
Score: 0.061
-
Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase. Acta Pharm Sin B. 2021 Jun; 11(6):1555-1567.
Score: 0.058